Castleview Partners’s iPath Series B S&P 500 VIX Mid-Term Futures ETN VXZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-31
Closed -$2.2K 770
2023
Q2
$2.2K Sell
31
-13,751
-100% -$1.18M ﹤0.01% 577
2023
Q1
$1.26M Buy
13,782
+2,083
+18% +$190K 1.12% 14
2022
Q4
$1.21M Sell
11,699
-3,967
-25% -$440K 1.18% 13
2022
Q3
$1.88M Buy
+15,666
New +$1.78M 1.8% 10

Other funds holding VXZ

Castleview Partners's VXZ Position: Q3 2023 in Review

Castleview Partners sold out of iPath Series B S&P 500 VIX Mid-Term Futures ETN (VXZ) in Q3 2023, closing a stake of 31 shares — an estimated $2.2K sold.

Castleview Partners first reported a position in VXZ in Q3 2022 and held it in 4 quarters. The position peaked at $1.88M in Q3 2022. 14 funds tracked by Wall St. Rank hold VXZ as of Q3 2023.

  • Castleview Partners reported no remaining iPath Series B S&P 500 VIX Mid-Term Futures ETN position as of Q3 2023 after selling out during the quarter.
  • Castleview Partners sold 31 iPath Series B S&P 500 VIX Mid-Term Futures ETN shares in Q3 2023, an estimated $2.2K.
  • Castleview Partners first reported a position in iPath Series B S&P 500 VIX Mid-Term Futures ETN in Q3 2022 and held it in 4 quarters.
  • Castleview Partners's iPath Series B S&P 500 VIX Mid-Term Futures ETN position peaked at $1.88M in Q3 2022.
  • 14 funds tracked by Wall St. Rank held iPath Series B S&P 500 VIX Mid-Term Futures ETN as of Q3 2023.

Based on Castleview Partners's 13F filing for Q3 2023, filed 26 Oct 2023.